| Abstrakt: |
A recent study from Aristotle University of Thessaloniki discusses the rare occurrence of thrombotic thrombocytopenic purpura (TTP) during pregnancy, a potentially life-threatening condition for both the mother and fetus. The study focuses on a case of a 34-year-old pregnant woman who conceived via assisted reproduction technology (ART) and was diagnosed with TTP at 13 weeks of gestation. The patient was treated with corticosteroids, plasmapheresis, and rituximab, and eventually developed mild ovarian hyperstimulation syndrome, which resolved on its own. The woman delivered a healthy baby via emergency cesarean section, and the postpartum follow-up was uneventful. The study emphasizes the importance of considering TTP in pregnant women with hemorrhagic risk and symptoms such as hematuria, anemia, and thrombocytopenia. [Extracted from the article] |
